Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001494650-21-000125
Filing Date
2021-11-15
Accepted
2021-11-15 16:34:35
Documents
64
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q optn-20210930.htm   iXBRL 10-Q 1086903
2 EX-10.1 optinoseatm-salesagreement.htm EX-10.1 290772
3 EX-31.1 optinose09-30x202110xqex311.htm EX-31.1 8373
4 EX-31.2 optinose09-30x202110xqex312.htm EX-31.2 8290
5 EX-32.1 optinose09-30x202110xqex321.htm EX-32.1 6201
6 EX-32.2 optinose9-30x202110xqex322.htm EX-32.2 6224
12 optn-20210930_g1.jpg GRAPHIC 10067
  Complete submission text file 0001494650-21-000125.txt   5348612

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optn-20210930.xsd EX-101.SCH 34115
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT optn-20210930_cal.xml EX-101.CAL 46649
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT optn-20210930_def.xml EX-101.DEF 189869
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT optn-20210930_lab.xml EX-101.LAB 468377
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optn-20210930_pre.xml EX-101.PRE 303464
13 EXTRACTED XBRL INSTANCE DOCUMENT optn-20210930_htm.xml XML 679331
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

EIN.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38241 | Film No.: 211411477
SIC: 2834 Pharmaceutical Preparations